DigitalDx Ventures - aVenture Asset Manager Research
Location
Menlo Park, CA, US
Founded
2019
DigitalDx Ventures is a majority woman-owned impact fund focusing on early-stage investments in digital health technologies. The firm leverages AI and big data to advance diagnostics for major global health issues, including cancer, cardiovascular and kidney health, Alzheimer's disease, and mental health. Their investment strategy prioritizes technologies that enable early and accurate detection, minimize invasiveness, and expand access to affordable treatment.
The fund's portfolio includes companies like Biotia, Nephrosant, and Trayt. DigitalDx Ventures boasts a team of successful Silicon Valley digital health investors, medical professionals, and legal experts. Led by Michele Colucci, the firm offers valuable industry connections and expertise to its portfolio companies. Their advisory board includes notable figures such as Deborah DiSanzo and Russ Altman, enhancing their ability to provide strategic guidance in the digital health sector.
DigitalDx Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Follow-on Investments1
Current Portfolio Count5
Top Investment Stages
Series A5 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
